Your browser doesn't support javascript.
loading
Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis.
Thibodeau, My Linh; Zhao, Eric Y; Reisle, Caralyn; Ch'ng, Carolyn; Wong, Hui-Li; Shen, Yaoqing; Jones, Martin R; Lim, Howard J; Young, Sean; Cremin, Carol; Pleasance, Erin; Zhang, Wei; Holt, Robert; Eirew, Peter; Karasinska, Joanna; Kalloger, Steve E; Taylor, Greg; Majounie, Elisa; Bonakdar, Melika; Zong, Zusheng; Bleile, Dustin; Chiu, Readman; Birol, Inanc; Gelmon, Karen; Lohrisch, Caroline; Mungall, Karen L; Mungall, Andrew J; Moore, Richard; Ma, Yussanne P; Fok, Alexandra; Yip, Stephen; Karsan, Aly; Huntsman, David; Schaeffer, David F; Laskin, Janessa; Marra, Marco A; Renouf, Daniel J; Jones, Steven J M; Schrader, Kasmintan A.
Afiliação
  • Thibodeau ML; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
  • Zhao EY; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Reisle C; Hereditary Cancer Program, BC Cancer, Vancouver, British Columbia V5Z 1H5, Canada.
  • Ch'ng C; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Wong HL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Shen Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Jones MR; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Lim HJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Young S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Cremin C; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Pleasance E; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada.
  • Zhang W; Cancer Genetics and Genomics Laboratory, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Holt R; Hereditary Cancer Program, BC Cancer, Vancouver, British Columbia V5Z 1H5, Canada.
  • Eirew P; Pancreas Centre BC, Vancouver, British Columbia V5Z 1L8, Canada.
  • Karasinska J; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Kalloger SE; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Taylor G; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
  • Majounie E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Bonakdar M; Department of Molecular Oncology, BC Cancer, Vancouver, British Columbia V5Z 1L3, Canada.
  • Zong Z; Pancreas Centre BC, Vancouver, British Columbia V5Z 1L8, Canada.
  • Bleile D; Pancreas Centre BC, Vancouver, British Columbia V5Z 1L8, Canada.
  • Chiu R; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
  • Birol I; The Canadian Centre for Applied Research in Cancer Control, Vancouver, British Columbia V5Z 1L3, Canada.
  • Gelmon K; Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Lohrisch C; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Mungall KL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Moore R; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Ma YP; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Fok A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Yip S; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
  • Karsan A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Huntsman D; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Schaeffer DF; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia V5Z 4E6, Canada.
  • Laskin J; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Renouf DJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
  • Schrader KA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia V5Z 4S6, Canada.
Cold Spring Harb Mol Case Stud ; 5(2)2019 04.
Article em En | MEDLINE | ID: mdl-30833417
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias da Mama / Carcinoma Ductal Pancreático / DNA Glicosilases / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias da Mama / Carcinoma Ductal Pancreático / DNA Glicosilases / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article